Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P2OZ
|
|||
Former ID |
DNC000419
|
|||
Drug Name |
Chemosensitizers
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H18ClN3SZn+2
|
|||
Canonical SMILES |
CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-].[Zn+2]
|
|||
InChI |
1S/C16H18N3S.ClH.Zn/c1-18(2)11-5-7-13-15(9-11)20-16-10-12(19(3)4)6-8-14(16)17-13;;/h5-10H,1-4H3;1H;/q+1;;+2/p-1
|
|||
InChIKey |
LXXWTKZXINWUFR-UHFFFAOYSA-M
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
SuperDrug ATC ID |
V03AB17
|
|||
SuperDrug CAS ID |
cas=000061734
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Multidrug resistance protein (MDR) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | P-glycoprotein as a drug target in the treatment of multidrug resistant cancer. Curr Drug Targets. 2000 Jul;1(1):85-99. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.